http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104803945-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_baeefdf679054cadf63ca9aba8d88468 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-46 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-46 |
| filingDate | 2015-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f71dd55c6bde274224c0e2750dd3e1b |
| publicationDate | 2015-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104803945-A |
| titleOfInvention | PTP (protein tyrosine phosphatase)1B inhibitors containing phenylthiazole and cyclopentadiene structures and application of PTP1B inhibitors |
| abstract | The invention relates to the field of type 2 diabetes mellitus related drugs, in particular to PTP (protein tyrosine phosphatase)1B inhibitors containing phenylthiazole and cyclopentadiene structures, preparation methods of the PTP1B inhibitors and an application of the PTP1B inhibitor in preparation of drugs for treating type 2 diabetes mellitus. The general formula is shown in the specification, wherein R is selected from H, C1-C3 alkyl and C3-C8 naphthenic base. |
| priorityDate | 2015-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 647.